Accentuation of imbalances
at macroeconomic level has been accounted to this lowest dip of rate in the last 9 years.
Bailey said: «The most vulnerable countries, which will be the worst affected — whether
at the macroeconomic level or at the household level — the poorest households spend upwards of 50 % of their income on food.
Not exact matches
«He's a guy who thinks
at the highest
levels — about government, about
macroeconomic issues, about geopolitical issues and about what's happening in our industry,» says Colleen Johnston, TD's chief financial officer, adding, «Despite all he's achieved, he's also a guy who can put himself in other people's shoes and think like a normal person.»
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global
macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the
levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or
at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Policymakers
at both the national and global
level will have to strengthen the financial and
macroeconomic policy mix.
These risks and uncertainties include competition and other economic conditions including fragmentation of the media landscape and competition from other media alternatives; changes in advertising demand, circulation
levels and audience shares; the Company's ability to develop and grow its online businesses; the Company's reliance on revenue from printing and distributing third - party publications; changes in newsprint prices;
macroeconomic trends and conditions; the Company's ability to adapt to technological changes; the Company's ability to realize benefits or synergies from acquisitions or divestitures or to operate its businesses effectively following acquisitions or divestitures; the Company's success in implementing expense mitigation efforts; the Company's reliance on third - party vendors for various services; adverse results from litigation, governmental investigations or tax - related proceedings or audits; the Company's ability to attract and retain employees; the Company's ability to satisfy pension and other postretirement employee benefit obligations; changes in accounting standards; the effect of labor strikes, lockouts and labor negotiations; regulatory and judicial rulings; the Company's indebtedness and ability to comply with debt covenants applicable to its debt facilities; the Company's ability to satisfy future capital and liquidity requirements; the Company's ability to access the credit and capital markets
at the times and in the amounts needed and on acceptable terms; and other events beyond the Company's control that may result in unexpected adverse operating results.
The presentation suggested that such a facility would allow the Committee to offer an overnight, risk - free instrument directly to a relatively wide range of market participants, perhaps complementing the payment of interest on excess reserves held by banks and thereby improving the Committee's ability to keep short - term market rates
at levels that it deems appropriate to achieve its
macroeconomic objectives.
High - profile, successful, and gold - agnostic investment - world luminaries assess the
macroeconomic risks of radical monetary policies and reach a similar conclusion: This will end badly: — Seth Klarman: «All the Trumans (reference: a 1998 movie [The Truman Show] in which the main character's entire life takes place on a TV set which he perceives as reality)-- the economists, fund managers, traders, market pundits — know
at some
level that the environment in which they operate is not what it seems on the surface....
Stretched valuations, high
levels of uncertainty about the
macroeconomic backdrop and tight correlations would seem to warrant a closer look
at assets that can help offer true diversification benefits and downside protection in the event of another synchronized decline across a whole spectrum of riskier assets.
«Inflation targeting» summarises the system widely adopted in the last two decades on a nation - by - nation basis, involving independent central banks using interest rates to keep inflation
at a target
level in the framework of a New Keynesian
macroeconomic model.
Your sources also prevent a very biased picture, the bit about pay - as - you - go pensions simply makes no sense on a
macroeconomic level and the Dutch system
at least is certainly not based mostly on this (and, in fact, very similar to the structure of the Danish and Finnish systems described in this article).
Some such refocusing was natural in 2010 against a backdrop of economic crisis and with most of the
macroeconomic levers being operated
at the UK
level.
PBL increased learning of
macroeconomics at the high school
level, as compared with traditional classes, in a sample of 252 students
at 11 high schools (Maxwell, Mergendoller & Bellisimo, 2005).
PBL modestly increased learning of
macroeconomics at the high school
level as compared with traditional classes.
Using data from 252 economics students
at 11 high schools and controlling for individual characteristics, most notably verbal ability, they found modest evidence that, in the aggregate, PBL increased learning of
macroeconomics at the high school
level as compared with traditional classes.
Before the crisis, when I was writing
at RealMoney.com, I usually encouraged taking the less risky
macroeconomic route, suggesting policies that would not increase debt
levels.
Ian Shepherdson, chief economist
at Pantheon
Macroeconomics, noted that the growth in spending is being funded by a fall in the saving rate, which is set to drop to 2.9 percent — its lowest
level in a decade — in the fourth quarter of 2017.
And this is also why in most cases even large disasters are a blip on the
macroeconomic screens of countries; but
at the local
level the story is very, very different.
At every
level, from
macroeconomic management to the day - to - day business of money markets, the tide is turning against fossil fuels.
The literature indicates that supplementing mitigation options with appropriate national
macroeconomic policies, and with social and local waste reduction strategies
at the company
level (Tata Steel, Ltd., 2005; BEE, 2006), has achieved some sustainability goals.
Looking
at it from a
macroeconomic level, higher oil prices are good for some industries, and yet ba...